inotuzumab
ucb pharmaceuticals,pfizer
['lymphoma', 'inotuzumab', 'inotuzumab ozogamicin', 'leukemia']
catch dr. noam kopmar's presentation titled, "a phase i trial of dose-adjusted epoch plus inotuzumab ozogamicin (ino) in adults with relapsed/refractory (r/r) b lymphoblastic leukemia/lymphoma (b-all)" at 3:12 pm ct at #asco23. see more highlights: 
Making life beyond cancer a reality.